REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 1.00 (0.96%)
Spread: 6.00 (5.882%)
Open: 104.00
High: 105.00
Low: 104.00
Prev. Close: 104.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement Re ActivIdentity Patent Claim

6 Oct 2008 07:00

RNS Number : 1139F
Intercede Group PLC
06 October 2008
 



6 OCTOBER 2008 

INTERCEDE GROUP plc

("Intercede" or "the Company")

Statement Relating To Possible Patent Infringement Suit

Intercede (AIM:IGP), the producer of the Intercede MyID™ Identity and Credential Management System, notes certain news reports indicating that ActivIdentity, formerly an Intercede business partner and OEM licensee of Intercede's smart card management software (see note 1 below), has filed an infringement suit against Intercede. 

Intercede has, to date, received no formal notification of action from ActivIdentity but after investigation has confirmed that a complaint was filed by ActivIdentity in the District Court of North California on 1 October 2008 concerning U.S. Patent 6,575,360. 

According to the details of the filing, this patent was issued to a 3rd party on 10 June 2003 and ownership was transferred to ActivIdentity on 6 July 2006. As such Intercede does not believe this patent was derived from ActivIdentity's own research and development activities.

As a software company, Intercede takes intellectual property rights very seriously and is scrupulous in protecting the rights of Intercede and other legitimate owners. Intercede retains leading patent lawyers to ensure that both its intellectual property and that of others is not infringed.

Intercede is aware of the '360' patent and has previously obtained expert opinion in the UK and US to confirm, beyond reasonable doubt, that none of its technology or products incorporate any intellectual property that may be protected by this patent.  

Intercede has previously discussed the patent at issue with ActivIdentity and was satisfied that it had demonstrated to ActivIdentity why none of Intercede's products infringe any valid claim of the patent. In the last eight months Intercede has received no communications from ActivIdentity to indicate they disagreed with this position.

 

Richard Parris, Chairman and Chief Executive of Intercede, said;

"The timing of this filing is questionable as it so closely follows recent press releases about Intercede's commercial successes in the US market. I believe ActivIdentity are resorting to the distraction tactic of litigation because their value proposition in the card management software market is failing (see note 2 below). Should ActivIdentity proceed with this action, Intercede will vigorously defend itself. 

As Intercede continues to achieve unprecedented commercial success with its technologically advanced solutions, it is inevitable that we will elicit a range of competitive responses from those companies who are threatened by Intercede's encroachment into their home markets. We welcome this particular challenge so that we can publicly demonstrate that the Intercede MyID system, supported by Intercede's own patented technology, is the most secure identity and credential management system available today. Unlike our competitors, all Intercede technology is developed in-house to ensure we do not rely on 3rd party originated intellectual property."

 

Intercede has today issued separately a positive trading update in respect of the 6 months ended 30 September 2008. Sales compared to the first half of the previous financial year have risen by 25% and a profit was generated at both pre and post tax level. The Directors of Intercede remain confident of the Company's future prospects.

Note 1: On 7 December 2001 and 23 April 2002, Intercede announced to the London Stock Exchange that ActivIdentity had paid Intercede an OEM license fee of $800,000 for an undisclosed number of Intercede MyID software licences (formerly branded as edefice). Full details of these announcements can be found on Intercede's web site, www.intercede.com.

Note 2: ActivIdentity reported a $2.0 million year-on-year decrease in card management software revenues in the 9 months to June 2008 (Source: Form10-Q Filing to the U.S. Securities and Exchange Commission for the Quarterly Period ended 30 June 2008). This is at a time when Intercede, a company focused exclusively on card management software, has experienced a substantial increase in revenues.

ENQUIRIES

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Pelham Public Relations

Tel. +44 (0)20 7743 6679

Archie Berens

Robert Koh

KBC Peel Hunt

Tel. + 44 (0)20 7418 8900

Richard Kauffer

Daniel Harris

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUGAUUUPRGRA
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.